158 related articles for article (PubMed ID: 35051421)
1. Oral fluoxetine treatment changes serotonergic sympatho-regulation in experimental type 1 diabetes.
García-Pedraza JÁ; Fernández-González JF; López C; Martín ML; Alarcón-Torrecillas C; Rodríguez-Barbero A; Morán A; García-Domingo M
Life Sci; 2022 Mar; 293():120335. PubMed ID: 35051421
[TBL] [Abstract][Full Text] [Related]
2. Vascular sympathetic neurotransmission and its serotonergic regulation are modified by chronic fluoxetine treatment.
García-Pedraza JÁ; López C; Fernández-González JF; Martín ML; Morán A; García-Domingo M
J Pharmacol Sci; 2021 Sep; 147(1):48-57. PubMed ID: 34294372
[TBL] [Abstract][Full Text] [Related]
3. Effect of sarpogrelate treatment on 5-HT modulation of vascular sympathetic innervation and platelet activity in diabetic rats.
Fernández-González JF; García-Pedraza JÁ; Marín-Quílez A; Bastida JM; Martín ML; Morán A; García-Domingo M
Biomed Pharmacother; 2022 Sep; 153():113276. PubMed ID: 35717784
[TBL] [Abstract][Full Text] [Related]
4. Diabetes-induced changes in the 5-hydroxytryptamine inhibitory receptors involved in the pressor effect elicited by sympathetic stimulation in the pithed rat.
García M; Morán A; Calama E; Martín ML; Barthelmebs M; Román LS
Br J Pharmacol; 2005 Jul; 145(5):593-601. PubMed ID: 15852039
[TBL] [Abstract][Full Text] [Related]
5. The 5-HT1-like receptors mediating inhibition of sympathetic vasopressor outflow in the pithed rat: operational correlation with the 5-HT1A, 5-HT1B and 5-HT1D subtypes.
Villalón CM; Centurión D; Rabelo G; de Vries P; Saxena PR; Sánchez-López A
Br J Pharmacol; 1998 Jul; 124(5):1001-11. PubMed ID: 9692787
[TBL] [Abstract][Full Text] [Related]
6. Chronic sarpogrelate treatment improves renal sympathetic hyperactivity in experimental diabetes.
Fernández-González JF; García-Pedraza JÁ; Terol-Úbeda AC; Martín ML; Morán A; García-Domingo M
Biomed Pharmacother; 2024 Jul; 176():116814. PubMed ID: 38820974
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological profile of 5-hydroxytryptamine-induced inhibition on the pressor effect elicited by sympathetic stimulation in long-term diabetic pithed rats.
Morán A; Restrepo B; de Urbina AV; García M; Martín ML; Román LS
Eur J Pharmacol; 2010 Sep; 643(1):70-7. PubMed ID: 20547148
[TBL] [Abstract][Full Text] [Related]
8. 5-HT1D receptor inhibits renal sympathetic neurotransmission by nitric oxide pathway in anesthetized rats.
García-Pedraza JÁ; García M; Martín ML; Morán A
Vascul Pharmacol; 2015 Sep; 72():172-80. PubMed ID: 26003124
[TBL] [Abstract][Full Text] [Related]
9. Role of peripheral 5-HT
García-Pedraza JÁ; Hernández-Abreu O; Morán A; Carretero J; García-Domingo M; Villalón CM
Sci Rep; 2020 Nov; 10(1):19358. PubMed ID: 33168874
[TBL] [Abstract][Full Text] [Related]
10. Chronic 5-HT
García-Pedraza JÁ; Hernández-Abreu O; García M; Morán A; Villalón CM
Can J Physiol Pharmacol; 2018 Apr; 96(4):328-336. PubMed ID: 28886249
[TBL] [Abstract][Full Text] [Related]
11. Peripheral 5-HT₁D and 5-HT₇ serotonergic receptors modulate sympathetic neurotransmission in chronic sarpogrelate treated rats.
García-Pedraza JÁ; García M; Martín ML; Gómez-Escudero J; Rodríguez-Barbero A; Román LS; Morán A
Eur J Pharmacol; 2013 Aug; 714(1-3):65-73. PubMed ID: 23769743
[TBL] [Abstract][Full Text] [Related]
12. Diabetes-induced changes in 5-hydroxytryptamine modulation of vagally-induced bradycardia in rat heart.
García M; Morán A; Martín ML; Ortizde Urbina AV; San Román L
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1199-206. PubMed ID: 17880377
[TBL] [Abstract][Full Text] [Related]
13. Fluoxetine Treatment Decreases Cardiac Vagal Input and Alters the Serotonergic Modulation of the Parasympathetic Outflow in Diabetic Rats.
García-Domingo M; García-Pedraza JÁ; Fernández-González JF; López C; Martín ML; Morán A
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628547
[TBL] [Abstract][Full Text] [Related]
14. Characterization of prejunctional 5-HT1 receptors that mediate the inhibition of pressor effects elicited by sympathetic stimulation in the pithed rat.
Morán A; Fernández MM; Velasco C; Martín ML; San Román L
Br J Pharmacol; 1998 Mar; 123(6):1205-13. PubMed ID: 9559906
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological profile of the 5-HT-induced inhibition of cardioaccelerator sympathetic outflow in pithed rats: correlation with 5-HT1 and putative 5-ht5A/5B receptors.
Sánchez-Lopez A; Centurión D; Vázquez E; Arulmani U; Saxena PR; Villalón CM
Br J Pharmacol; 2003 Oct; 140(4):725-35. PubMed ID: 14504136
[TBL] [Abstract][Full Text] [Related]
16. Peripheral 5-HT1A and 5-HT7 serotonergic receptors modulate parasympathetic neurotransmission in long-term diabetic rats.
Restrepo B; Martín ML; San Román L; Morán A
Exp Diabetes Res; 2010; 2010():686734. PubMed ID: 21403818
[TBL] [Abstract][Full Text] [Related]
17. Renal Sympathetic Hyperactivity in Diabetes Is Modulated by 5-HT
Fernández-González JF; García-Pedraza JÁ; Ordóñez JL; Terol-Úbeda AC; Martín ML; Morán A; García-Domingo M
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674892
[TBL] [Abstract][Full Text] [Related]
18. [Role of serotonin receptors in vascular tone in the pithed rat].
Sánchez-López A; Centurión D; Lozano-Cuenca J; Muñoz-Islas E; Cobos-Puc LE; Villalón CM
Arch Cardiol Mex; 2009 Dec; 79 Suppl 2():83-94. PubMed ID: 20361490
[TBL] [Abstract][Full Text] [Related]
19. The nitric oxide synthesis/pathway mediates the inhibitory serotoninergic responses of the pressor effect elicited by sympathetic stimulation in diabetic pithed rats.
García M; Morán A; Luisa Martín M; Barthelmebs M; San Román L
Eur J Pharmacol; 2006 May; 537(1-3):126-34. PubMed ID: 16630608
[TBL] [Abstract][Full Text] [Related]
20. Fluoxetine oral treatment discloses 5-HT
López C; Gómez-Roso M; García-Pedraza JÁ; Martín ML; Morán A; García-Domingo M
Can J Physiol Pharmacol; 2019 Feb; 97(2):90-98. PubMed ID: 30462556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
